Since its foundation in 1997, Probiodrug has managed to attract a selected group of renowned investors and has raised a total of appr. $71 million in private equity.

The Company┬┤s key investors are:
BB Biotech
Edmond de Rothschild Investment Partners
Life Sciences Partners

Biogen Idec New Ventures
TVM Capital
HBM BioVentures
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH
CFH GmbH - LBBW Group
Tbg Technologie-Beteiligungs-Gesellschaft (now: KfW Mittelstandsbank)
Wellington Management
Bayern Kapital GmbH